The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH 2023 | Updates in the WHO classification for lymphoma and how this may impact clinical practice
Daphne de Jong, MD, PhD , Amsterdam UMC, Amsterdam, The Netherlands, shares some insights into the recently updated World Health Organization (WHO)-HAEM5 classification for lymphoma. Prof. de Jong first explains how these updates may impact clinical practice, and further comments on the applicability of this updated classification system on a global scale. This interview took place at the 63rd Annual Scientific Meeting of the British Society for Haematology (BSH) 2023, held in Birmingham, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
